A

Alamar Biosciences

Automates high-throughput proteomics for biomarker detection

Director BioPharma Business Development - US East

Business Development & PartnershipsConfirmed live in the last 24 hours
Full-timeBoston, MA, USA

About the Job

Requirements

  • An advanced degree (PhD, MD, or MBA) in life sciences or a related field.
  • At least 10 years of experience in sales or business development; experience in proteomics, diagnostics, or biotech is preferred.
  • A customer-centric approach and the ability to understand client needs and translate them into product or partnership opportunities.
  • A proven track record of closing strategic deals and managing complex partnerships.
  • A deep understanding of drug development, clinical trial design, biomarker validation, and regulatory frameworks.
  • Innovative thinking to identify novel opportunities for technology application and growth.
  • Strong communication, negotiation, and leadership skills.

Responsibilities

  • Identify, negotiate, and manage commercial opportunities in the BioPharma and CRO market segment.
  • Develop and execute strategies to expand Alamar’s presence in drug discovery and translational research.
  • Collaborate with R&D, regulatory, and commercial teams to align product development with market needs.
  • Build relationships with key opinion leaders, clinical researchers, and decision-makers in BioPharma and CROs.
  • Provide input on clinical validation strategies and regulatory pathways, including FDA and CE-IVD.
  • Drive revenue through commercial partnerships and strategic deals.
  • Travel up to 50% domestically and internationally may be required.

About the Company

Alamar Biosciences

Automates high-throughput proteomics for biomarker detection

Alamar Biosciences provides access to a high-throughput proteomics platform built around NULISA™, a sensitive method for detecting and measuring proteins, and the ARGO™ system, a fully automated workflow for profiling hundreds to thousands of protein targets. It serves researchers and clinicians who need to detect low-abundance protein biomarkers with multiplexing capabilities, paying for use of the technology and platform rather than selling a standalone instrument. The core difference from competitors is its combination of ultra-sensitive protein detection across a wide range and an automated, scalable workflow that reduces the need for specialized expertise, enabling single-target or large-scale multiplex experiments. The company’s goal is to advance understanding of protein roles in health and disease, enabling early disease detection and the development of new diagnostics and treatments through repeatable, high-throughput proteomics.

Company size
201-500
Company stage
IPO
Headquarters
Hayward, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Alamar Biosciences

See more jobs